nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Dyspnoea—Vandetanib—thyroid cancer	0.00466	0.00466	CcSEcCtD
Perflutren—Feeling hot—Epirubicin—thyroid cancer	0.00465	0.00465	CcSEcCtD
Perflutren—Tinnitus—Sorafenib—thyroid cancer	0.00463	0.00463	CcSEcCtD
Perflutren—Flushing—Sorafenib—thyroid cancer	0.0046	0.0046	CcSEcCtD
Perflutren—Cardiac disorder—Sorafenib—thyroid cancer	0.0046	0.0046	CcSEcCtD
Perflutren—Dyspepsia—Vandetanib—thyroid cancer	0.0046	0.0046	CcSEcCtD
Perflutren—Ventricular arrhythmia—Doxorubicin—thyroid cancer	0.00456	0.00456	CcSEcCtD
Perflutren—Albuminuria—Doxorubicin—thyroid cancer	0.00452	0.00452	CcSEcCtD
Perflutren—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00451	0.00451	CcSEcCtD
Perflutren—Fatigue—Vandetanib—thyroid cancer	0.0045	0.0045	CcSEcCtD
Perflutren—Angiopathy—Sorafenib—thyroid cancer	0.0045	0.0045	CcSEcCtD
Perflutren—Immune system disorder—Sorafenib—thyroid cancer	0.00448	0.00448	CcSEcCtD
Perflutren—Injection site pain—Epirubicin—thyroid cancer	0.00447	0.00447	CcSEcCtD
Perflutren—Rigors—Epirubicin—thyroid cancer	0.00447	0.00447	CcSEcCtD
Perflutren—Mediastinal disorder—Sorafenib—thyroid cancer	0.00447	0.00447	CcSEcCtD
Perflutren—Pain—Vandetanib—thyroid cancer	0.00447	0.00447	CcSEcCtD
Perflutren—Arrhythmia—Sorafenib—thyroid cancer	0.00443	0.00443	CcSEcCtD
Perflutren—Rash erythematous—Doxorubicin—thyroid cancer	0.00441	0.00441	CcSEcCtD
Perflutren—Erythema—Sorafenib—thyroid cancer	0.00432	0.00432	CcSEcCtD
Perflutren—Feeling hot—Doxorubicin—thyroid cancer	0.0043	0.0043	CcSEcCtD
Perflutren—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00427	0.00427	CcSEcCtD
Perflutren—Dysgeusia—Sorafenib—thyroid cancer	0.00423	0.00423	CcSEcCtD
Perflutren—Muscle spasms—Sorafenib—thyroid cancer	0.00415	0.00415	CcSEcCtD
Perflutren—Injection site pain—Doxorubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Perflutren—Rigors—Doxorubicin—thyroid cancer	0.00414	0.00414	CcSEcCtD
Perflutren—Abdominal pain—Vandetanib—thyroid cancer	0.00413	0.00413	CcSEcCtD
Perflutren—Body temperature increased—Vandetanib—thyroid cancer	0.00413	0.00413	CcSEcCtD
Perflutren—Ventricular extrasystoles—Epirubicin—thyroid cancer	0.00404	0.00404	CcSEcCtD
Perflutren—Angioedema—Sorafenib—thyroid cancer	0.00395	0.00395	CcSEcCtD
Perflutren—Syncope—Sorafenib—thyroid cancer	0.00387	0.00387	CcSEcCtD
Perflutren—Leukopenia—Sorafenib—thyroid cancer	0.00387	0.00387	CcSEcCtD
Perflutren—Loss of consciousness—Sorafenib—thyroid cancer	0.0038	0.0038	CcSEcCtD
Perflutren—Cough—Sorafenib—thyroid cancer	0.00377	0.00377	CcSEcCtD
Perflutren—Asthenia—Vandetanib—thyroid cancer	0.00375	0.00375	CcSEcCtD
Perflutren—Ventricular extrasystoles—Doxorubicin—thyroid cancer	0.00374	0.00374	CcSEcCtD
Perflutren—Hypertension—Sorafenib—thyroid cancer	0.00373	0.00373	CcSEcCtD
Perflutren—Pruritus—Vandetanib—thyroid cancer	0.0037	0.0037	CcSEcCtD
Perflutren—Neck pain—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Perflutren—Musculoskeletal pain—Epirubicin—thyroid cancer	0.0037	0.0037	CcSEcCtD
Perflutren—Arthralgia—Sorafenib—thyroid cancer	0.00368	0.00368	CcSEcCtD
Perflutren—Myalgia—Sorafenib—thyroid cancer	0.00368	0.00368	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00365	0.00365	CcSEcCtD
Perflutren—Ventricular tachycardia—Epirubicin—thyroid cancer	0.00365	0.00365	CcSEcCtD
Perflutren—Injection site reaction—Epirubicin—thyroid cancer	0.00363	0.00363	CcSEcCtD
Perflutren—Dry mouth—Sorafenib—thyroid cancer	0.0036	0.0036	CcSEcCtD
Perflutren—Diarrhoea—Vandetanib—thyroid cancer	0.00357	0.00357	CcSEcCtD
Perflutren—Influenza like illness—Epirubicin—thyroid cancer	0.00355	0.00355	CcSEcCtD
Perflutren—Anaphylactic shock—Sorafenib—thyroid cancer	0.00352	0.00352	CcSEcCtD
Perflutren—Shock—Sorafenib—thyroid cancer	0.00347	0.00347	CcSEcCtD
Perflutren—Nervous system disorder—Sorafenib—thyroid cancer	0.00346	0.00346	CcSEcCtD
Perflutren—Dizziness—Vandetanib—thyroid cancer	0.00346	0.00346	CcSEcCtD
Perflutren—Skin disorder—Sorafenib—thyroid cancer	0.00342	0.00342	CcSEcCtD
Perflutren—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Perflutren—Neck pain—Doxorubicin—thyroid cancer	0.00342	0.00342	CcSEcCtD
Perflutren—Ventricular tachycardia—Doxorubicin—thyroid cancer	0.00338	0.00338	CcSEcCtD
Perflutren—Injection site reaction—Doxorubicin—thyroid cancer	0.00336	0.00336	CcSEcCtD
Perflutren—Cramps of lower extremities—Epirubicin—thyroid cancer	0.00335	0.00335	CcSEcCtD
Perflutren—Coma—Epirubicin—thyroid cancer	0.00334	0.00334	CcSEcCtD
Perflutren—Vomiting—Vandetanib—thyroid cancer	0.00332	0.00332	CcSEcCtD
Perflutren—Rash—Vandetanib—thyroid cancer	0.00329	0.00329	CcSEcCtD
Perflutren—Dermatitis—Vandetanib—thyroid cancer	0.00329	0.00329	CcSEcCtD
Perflutren—Influenza like illness—Doxorubicin—thyroid cancer	0.00328	0.00328	CcSEcCtD
Perflutren—Headache—Vandetanib—thyroid cancer	0.00327	0.00327	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00321	0.00321	CcSEcCtD
Perflutren—Hypertonia—Epirubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Perflutren—Abnormal vision—Epirubicin—thyroid cancer	0.00318	0.00318	CcSEcCtD
Perflutren—Dyspnoea—Sorafenib—thyroid cancer	0.00314	0.00314	CcSEcCtD
Perflutren—Lymphadenopathy—Epirubicin—thyroid cancer	0.00311	0.00311	CcSEcCtD
Perflutren—Nausea—Vandetanib—thyroid cancer	0.0031	0.0031	CcSEcCtD
Perflutren—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.0031	0.0031	CcSEcCtD
Perflutren—Dyspepsia—Sorafenib—thyroid cancer	0.0031	0.0031	CcSEcCtD
Perflutren—Coma—Doxorubicin—thyroid cancer	0.00309	0.00309	CcSEcCtD
Perflutren—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00304	0.00304	CcSEcCtD
Perflutren—Fatigue—Sorafenib—thyroid cancer	0.00304	0.00304	CcSEcCtD
Perflutren—Pain—Sorafenib—thyroid cancer	0.00301	0.00301	CcSEcCtD
Perflutren—Hypertonia—Doxorubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Perflutren—Abnormal vision—Doxorubicin—thyroid cancer	0.00295	0.00295	CcSEcCtD
Perflutren—Cardiac failure congestive—Epirubicin—thyroid cancer	0.00292	0.00292	CcSEcCtD
Perflutren—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00288	0.00288	CcSEcCtD
Perflutren—Lymphadenopathy—Doxorubicin—thyroid cancer	0.00287	0.00287	CcSEcCtD
Perflutren—Hot flush—Epirubicin—thyroid cancer	0.00283	0.00283	CcSEcCtD
Perflutren—Menopausal symptoms—Epirubicin—thyroid cancer	0.00281	0.00281	CcSEcCtD
Perflutren—Urticaria—Sorafenib—thyroid cancer	0.0028	0.0028	CcSEcCtD
Perflutren—Body temperature increased—Sorafenib—thyroid cancer	0.00279	0.00279	CcSEcCtD
Perflutren—Abdominal pain—Sorafenib—thyroid cancer	0.00279	0.00279	CcSEcCtD
Perflutren—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00274	0.00274	CcSEcCtD
Perflutren—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.0027	0.0027	CcSEcCtD
Perflutren—Hot flush—Doxorubicin—thyroid cancer	0.00262	0.00262	CcSEcCtD
Perflutren—Menopausal symptoms—Doxorubicin—thyroid cancer	0.0026	0.0026	CcSEcCtD
Perflutren—Hypersensitivity—Sorafenib—thyroid cancer	0.0026	0.0026	CcSEcCtD
Perflutren—Face oedema—Epirubicin—thyroid cancer	0.00256	0.00256	CcSEcCtD
Perflutren—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Perflutren—Asthenia—Sorafenib—thyroid cancer	0.00253	0.00253	CcSEcCtD
Perflutren—Cardiac arrest—Epirubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Perflutren—Pruritus—Sorafenib—thyroid cancer	0.00249	0.00249	CcSEcCtD
Perflutren—Dry skin—Epirubicin—thyroid cancer	0.00243	0.00243	CcSEcCtD
Perflutren—Diarrhoea—Sorafenib—thyroid cancer	0.00241	0.00241	CcSEcCtD
Perflutren—Face oedema—Doxorubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Perflutren—Cardiac arrest—Doxorubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Perflutren—Dizziness—Sorafenib—thyroid cancer	0.00233	0.00233	CcSEcCtD
Perflutren—Eosinophilia—Epirubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Perflutren—Dry skin—Doxorubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Perflutren—Vomiting—Sorafenib—thyroid cancer	0.00224	0.00224	CcSEcCtD
Perflutren—Rash—Sorafenib—thyroid cancer	0.00222	0.00222	CcSEcCtD
Perflutren—Dermatitis—Sorafenib—thyroid cancer	0.00222	0.00222	CcSEcCtD
Perflutren—Headache—Sorafenib—thyroid cancer	0.00221	0.00221	CcSEcCtD
Perflutren—Eosinophilia—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Perflutren—Nausea—Sorafenib—thyroid cancer	0.00209	0.00209	CcSEcCtD
Perflutren—Neuropathy peripheral—Epirubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Perflutren—Conjunctivitis—Epirubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Perflutren—Bradycardia—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Perflutren—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Perflutren—Haemoglobin—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Perflutren—Rhinitis—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Perflutren—Conjunctivitis—Doxorubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Perflutren—Haemorrhage—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Perflutren—Hypoaesthesia—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Perflutren—Pharyngitis—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Perflutren—Connective tissue disorder—Epirubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Perflutren—Visual impairment—Epirubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Perflutren—Bradycardia—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Perflutren—Eye disorder—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Perflutren—Tinnitus—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Perflutren—Haemoglobin—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Perflutren—Cardiac disorder—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Perflutren—Flushing—Epirubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Perflutren—Rhinitis—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Perflutren—Haemorrhage—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Perflutren—Hypoaesthesia—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Perflutren—Pharyngitis—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Perflutren—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Perflutren—Angiopathy—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Perflutren—Immune system disorder—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Perflutren—Mediastinal disorder—Epirubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Perflutren—Chills—Epirubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Perflutren—Arrhythmia—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Perflutren—Visual impairment—Doxorubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Perflutren—Erythema—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Perflutren—Eye disorder—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Perflutren—Tinnitus—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Perflutren—Cardiac disorder—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Perflutren—Flushing—Doxorubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Perflutren—Dysgeusia—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Perflutren—Back pain—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Perflutren—Angiopathy—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Perflutren—Muscle spasms—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Perflutren—Immune system disorder—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Perflutren—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Perflutren—Chills—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Perflutren—Arrhythmia—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Perflutren—Vision blurred—Epirubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Perflutren—Ill-defined disorder—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Perflutren—Erythema—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Perflutren—Agitation—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Perflutren—Dysgeusia—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Perflutren—Malaise—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Perflutren—Vertigo—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Perflutren—Syncope—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Perflutren—Leukopenia—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Perflutren—Back pain—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Perflutren—Muscle spasms—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Perflutren—Palpitations—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Perflutren—Loss of consciousness—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Perflutren—Cough—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Perflutren—Vision blurred—Doxorubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Perflutren—Convulsion—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Perflutren—Hypertension—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Perflutren—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Perflutren—Myalgia—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Chest pain—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Arthralgia—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Agitation—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Perflutren—Discomfort—Epirubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Perflutren—Malaise—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Perflutren—Dry mouth—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Perflutren—Vertigo—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Perflutren—Syncope—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Perflutren—Leukopenia—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Perflutren—Palpitations—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Perflutren—Oedema—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Perflutren—Anaphylactic shock—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Perflutren—Loss of consciousness—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Perflutren—Cough—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Perflutren—Shock—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Convulsion—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Nervous system disorder—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Perflutren—Hypertension—Doxorubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Tachycardia—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Skin disorder—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Perflutren—Hyperhidrosis—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Chest pain—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Myalgia—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Arthralgia—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Perflutren—Discomfort—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Perflutren—Dry mouth—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Perflutren—Hypotension—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Perflutren—Oedema—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Shock—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Perflutren—Nervous system disorder—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Tachycardia—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Perflutren—Skin disorder—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Paraesthesia—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Perflutren—Dyspnoea—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Perflutren—Dyspepsia—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Perflutren—Hypotension—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Perflutren—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Perflutren—Fatigue—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Perflutren—Pain—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Perflutren—Paraesthesia—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Perflutren—Dyspnoea—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Feeling abnormal—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Perflutren—Dyspepsia—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Perflutren—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Fatigue—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Perflutren—Urticaria—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Pain—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Abdominal pain—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Body temperature increased—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perflutren—Feeling abnormal—Doxorubicin—thyroid cancer	0.000993	0.000993	CcSEcCtD
Perflutren—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000986	0.000986	CcSEcCtD
Perflutren—Hypersensitivity—Epirubicin—thyroid cancer	0.00096	0.00096	CcSEcCtD
Perflutren—Urticaria—Doxorubicin—thyroid cancer	0.000957	0.000957	CcSEcCtD
Perflutren—Body temperature increased—Doxorubicin—thyroid cancer	0.000953	0.000953	CcSEcCtD
Perflutren—Abdominal pain—Doxorubicin—thyroid cancer	0.000953	0.000953	CcSEcCtD
Perflutren—Asthenia—Epirubicin—thyroid cancer	0.000935	0.000935	CcSEcCtD
Perflutren—Pruritus—Epirubicin—thyroid cancer	0.000922	0.000922	CcSEcCtD
Perflutren—Diarrhoea—Epirubicin—thyroid cancer	0.000891	0.000891	CcSEcCtD
Perflutren—Hypersensitivity—Doxorubicin—thyroid cancer	0.000888	0.000888	CcSEcCtD
Perflutren—Asthenia—Doxorubicin—thyroid cancer	0.000865	0.000865	CcSEcCtD
Perflutren—Dizziness—Epirubicin—thyroid cancer	0.000861	0.000861	CcSEcCtD
Perflutren—Pruritus—Doxorubicin—thyroid cancer	0.000853	0.000853	CcSEcCtD
Perflutren—Vomiting—Epirubicin—thyroid cancer	0.000828	0.000828	CcSEcCtD
Perflutren—Diarrhoea—Doxorubicin—thyroid cancer	0.000825	0.000825	CcSEcCtD
Perflutren—Rash—Epirubicin—thyroid cancer	0.000821	0.000821	CcSEcCtD
Perflutren—Dermatitis—Epirubicin—thyroid cancer	0.000821	0.000821	CcSEcCtD
Perflutren—Headache—Epirubicin—thyroid cancer	0.000816	0.000816	CcSEcCtD
Perflutren—Dizziness—Doxorubicin—thyroid cancer	0.000797	0.000797	CcSEcCtD
Perflutren—Nausea—Epirubicin—thyroid cancer	0.000774	0.000774	CcSEcCtD
Perflutren—Vomiting—Doxorubicin—thyroid cancer	0.000766	0.000766	CcSEcCtD
Perflutren—Rash—Doxorubicin—thyroid cancer	0.00076	0.00076	CcSEcCtD
Perflutren—Dermatitis—Doxorubicin—thyroid cancer	0.000759	0.000759	CcSEcCtD
Perflutren—Headache—Doxorubicin—thyroid cancer	0.000755	0.000755	CcSEcCtD
Perflutren—Nausea—Doxorubicin—thyroid cancer	0.000716	0.000716	CcSEcCtD
